ViviCells Financial Statements From 2010 to 2025

VCII Stock  USD 0.0001  0.00  0.00%   
ViviCells International's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing ViviCells International's valuation are provided below:
Gross Profit
1.1 M
Profit Margin
(0.09)
Market Capitalization
23.4 K
Revenue
5.1 M
Quarterly Revenue Growth
(0.27)
We have found eighty-four available fundamental trend indicators for ViviCells International, which can be analyzed and compared to other ratios and to its competition. Traders should compare all of ViviCells International current fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 4.6 M. Enterprise Value is estimated to decrease to about 4.7 M

ViviCells International Total Revenue

3.34 Million

Check ViviCells International financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ViviCells International's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 820 K, as well as many indicators such as Price To Sales Ratio of 17.1 K, Dividend Yield of 0.0 or PTB Ratio of 6.49. ViviCells financial statements analysis is a perfect complement when working with ViviCells International Valuation or Volatility modules.
  
Build AI portfolio with ViviCells Stock
Check out the analysis of ViviCells International Correlation against competitors.
For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.

ViviCells International Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.9 M6.1 M5.2 M
Slightly volatile
Other Current Liabilities239.2 K382.9 K315.8 K
Slightly volatile
Total Current Liabilities684.1 K780.4 K678.2 K
Slightly volatile
Total Stockholder Equity1.3 M2.2 M1.8 M
Slightly volatile
Net Tangible Assets1.2 M2.2 M1.8 M
Pretty Stable
Accounts Payable272.7 K267.4 K299.2 K
Slightly volatile
Cash22.9 K34 K28.3 K
Slightly volatile
Other Assets14.7 K23.2 K19.2 K
Slightly volatile
Long Term Debt2.2 M2.4 M2.6 M
Slightly volatile
Net Receivables3.2 MM3.5 M
Slightly volatile
Inventory1.5 M1.9 M1.6 M
Slightly volatile
Total Liabilities3.7 M3.9 M3.4 M
Slightly volatile
Short and Long Term Debt23.9 K25.7 K22.5 K
Slightly volatile
Total Current Assets4.8 MM5.1 M
Slightly volatile
Intangible Assets25.3 K26.6 K34.2 K
Slightly volatile
Common Stock75.4 K108.9 K91.1 K
Slightly volatile
Property Plant Equipment88 K110.7 K94.6 K
Slightly volatile

ViviCells International Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative820 KM881.9 K
Slightly volatile
Total Revenue3.3 M4.3 M3.7 M
Slightly volatile
Gross Profit1.3 MM1.6 M
Slightly volatile
Other Operating Expenses4.6 K3.8 K4.7 K
Slightly volatile
Cost Of Revenue2.1 M2.4 MM
Slightly volatile
Total Operating Expenses2.9 M3.4 M2.9 M
Slightly volatile

ViviCells International Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock787828727
Slightly volatile
Net Borrowings1.3 M1.4 M1.2 M
Slightly volatile
Depreciation42.2 K31.3 K36.1 K
Slightly volatile
Capital Expenditures37.5 K56.4 K47.3 K
Slightly volatile
Total Cash From Financing Activities1.5 M1.5 M1.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio17.1 K19.2 K21 K
Slightly volatile
PTB Ratio6.496.842.9 K
Slightly volatile
Days Sales Outstanding242272297
Slightly volatile
Book Value Per Share0.00680.00720.0107
Slightly volatile
PB Ratio6.496.842.9 K
Slightly volatile
EV To Sales17.1 K19.2 K21 K
Slightly volatile
Inventory Turnover1.341.51.638
Slightly volatile
Days Of Inventory On Hand175197215
Slightly volatile
Payables Turnover7.348.269.0065
Slightly volatile
Capex To Revenue0.00930.01040.0114
Slightly volatile
Cash Per Share0.00.02.0E-4
Slightly volatile
Days Payables Outstanding31.8235.7939.0201
Slightly volatile
Income Quality67.075.3782.1752
Slightly volatile
Intangibles To Total Assets0.00440.0050.0054
Slightly volatile
Current Ratio0.04230.04460.5355
Slightly volatile
Tangible Book Value Per Share0.00680.00720.0106
Slightly volatile
Receivables Turnover0.971.091.1837
Slightly volatile
Shareholders Equity Per Share0.00680.00720.0107
Slightly volatile
Debt To Equity0.110.120.1788
Slightly volatile
Capex Per Share0.00150.00170.0018
Slightly volatile
Revenue Per Share0.130.150.1594
Slightly volatile
Interest Debt Per Share7.0E-47.0E-40.0083
Slightly volatile
Debt To Assets0.190.10.1177
Pretty Stable
Operating Cycle417469512
Slightly volatile
Price Book Value Ratio6.496.842.9 K
Slightly volatile
Price Earnings To Growth Ratio4.327.314.0862
Slightly volatile
Days Of Payables Outstanding31.8235.7939.0201
Slightly volatile
Pretax Profit Margin0.04090.0460.0501
Slightly volatile
Effective Tax Rate0.860.961.0471
Slightly volatile
Company Equity Multiplier1.611.321.2866
Pretty Stable
Long Term Debt To Capitalization0.450.510.552
Slightly volatile
Total Debt To Capitalization0.210.110.1274
Slightly volatile
Debt Equity Ratio0.110.120.1788
Slightly volatile
Quick Ratio0.04230.04460.4181
Slightly volatile
Cash Ratio0.03310.03490.1642
Slightly volatile
Cash Conversion Cycle385433473
Slightly volatile
Days Of Inventory Outstanding175197215
Slightly volatile
Days Of Sales Outstanding242272297
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.830.941.0211
Slightly volatile
Price To Book Ratio6.496.842.9 K
Slightly volatile
Fixed Asset Turnover35.2239.6243.1939
Slightly volatile
Debt Ratio0.190.10.1177
Pretty Stable
Price Sales Ratio17.1 K19.2 K21 K
Slightly volatile
Asset Turnover0.640.720.7815
Slightly volatile
Gross Profit Margin0.290.320.3501
Slightly volatile
Price Fair Value6.496.842.9 K
Slightly volatile

ViviCells International Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.6 M4.8 M5.7 B
Slightly volatile
Enterprise Value4.7 M4.9 M5.7 B
Slightly volatile

About ViviCells International Financial Statements

Investors use fundamental indicators, such as ViviCells International's revenue or net income, to determine how well the company is positioned to perform in the future. Although ViviCells International's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Total Revenue4.3 M3.3 M
Cost Of Revenue2.4 M2.1 M
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.15  0.13 
Ebit Per Revenue(0.02)(0.02)

Currently Active Assets on Macroaxis

When determining whether ViviCells International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ViviCells International's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vivicells International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vivicells International Stock:
Check out the analysis of ViviCells International Correlation against competitors.
For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Independent Power and Renewable Electricity Producers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ViviCells International. If investors know ViviCells will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ViviCells International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth
(0.27)
The market value of ViviCells International is measured differently than its book value, which is the value of ViviCells that is recorded on the company's balance sheet. Investors also form their own opinion of ViviCells International's value that differs from its market value or its book value, called intrinsic value, which is ViviCells International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ViviCells International's market value can be influenced by many factors that don't directly affect ViviCells International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ViviCells International's value and its price as these two are different measures arrived at by different means. Investors typically determine if ViviCells International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ViviCells International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.